SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-02-012428
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
9
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2073246z10-k.htm 10-K 471762
3 EX-10.21 a2073246zex-10_21.htm EX-10.21 8801
4 EXHIBIT 10.22 a2073246zex-10_22.htm EX-10.22 146713
5 EXHIBIT 10.23 a2073246zex-10_23.htm EX-10.23 132631
6 EXHIBIT 10.24 a2073246zex-10_24.htm EX-10.24 143299
7 EXHIBIT 10.25 a2073246zex-10_25.htm EX-10.25 220695
8 EXHIBIT 10.26 a2073246zex-10_26.htm EX-10.26 93897
9 EXHIBIT 21 a2073246zex-21.htm EX-21 1060
10 EXHIBIT 23 a2073246zex-23.htm EX-23 3025
  Complete submission text file 0000912057-02-012428.txt   1224303
Mailing Address 410 W. HARRISON 410 W. HARRISON SEATTLE WA 98119
Business Address 410 W HARRISON ST SEATTLE WA 98119 206-286-25
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 02592772
SIC: 2835 In Vitro & In Vivo Diagnostic Substances